Hohlfeld R
Institute for Clinical Neuroimmunology, Klinikum Grosshadern, University of Munich, Germany.
Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1697-710. doi: 10.1098/rstb.1999.0513.
This review first addresses several general aspects of the immunotherapy of multiple sclerosis. Next, two approved immunomodulatory treatments, interferon-beta and copolymer-1 (glatiramer acetate), are reviewed in more detail. Finally, other immunosuppressive therapies and experimental strategies are briefly discussed.
本综述首先阐述了多发性硬化症免疫疗法的几个一般方面。接下来，将更详细地回顾两种已获批准的免疫调节治疗方法，即β-干扰素和共聚肽-1（醋酸格拉替雷）。最后，简要讨论其他免疫抑制疗法和实验策略。
Zotero 插件